Sartorius AG
SARTF
Updated: 23/09/2026, 15:36:12
Sartorius AG engages in the provision of solutions for biopharmaceutical research. It operates through following divisions: Bioprocess Solutions (BPS), and Lab Products and Service (LPS). The Bioprocess Solutions division focuses on single-use solutions, helps customers manufacture biotech medications and vaccines safely and efficiently. The Lab Products and services division serves the needs of laboratories performing research and quality control at pharma and biopharma companies and those of academic research institutes. The company was founded by Florence Sartorius, Sr. in 1870 and is headquartered in Goettingen, Germany.
No summaries found.
- Share price
- $243.86
- Market cap
- $16.84B
- Exchange
- OTC
- Currency
- USD
- CEO
- Michael Grosse
- Employees
- 14,042
- IPO date
- 22/09/2010
- Beta
- 1.473
- Last dividend
- $0.00
- Day range
- $212.80 – $243.86
- 52-week range
- $181.58 – $243.86
- 1-day performance
- 7.35%
- 1-year performance
- 34.30%
- Current drawdown (1Y)
- 0.00%
- CIK
- N/A
- CUSIP
- N/A
- ISIN
- DE0007165607
- Created
- 07/12/2025, 14:06:36
- Last update
- 23/09/2026, 15:36:12
Track Sartorius AG with an AI analyst
See which prediction-market events move SARTF, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.